The Chronic disease management market overview and analysis by solution, delivery mode, application, end user and region – forecast till 2030. MRFR (Market Research Future) expects the chronic disease management market 2023 to post a significant CAGR of 13.82% between 2022-2030 (projection period). Along with the report, we will include a COVID-19 impact analysis and a list of all the significant events that have occurred since the outbreak of the coronavirus disease.
COVID-19 Impact on Chronic Disease Management Market
According to the most recent study on SARS-CoV-2 hospitalised patients in the United States, modern EHR systems were used to draw the conclusion that diabetes, obesity, and hypertension are the three main chronic diseases gaining ground as a result of the pandemic. Of the 2,634 patients, 41.7% were obese, 33.8% had diabetes, and 56.6% had high blood pressure. According to the Department of Health and Social Care in England, the proportion of patients who are now receiving treatment for chronic diseases is about 70% of total expenditures on health and social care.
Despite the global lockdown, the majority of cash and resources have been devoted to containing the unique coronavirus epidemic, which is still out of control. The treatment of people with chronic diseases is being delayed as a result of this problem. The COVID-19 outbreak has increased the usage of multiple digital platforms, though, which can be advantageous for the care management market and increase demand for chronic illness management solutions.
Primary Drivers and Challenges
Being more prone to obesity, diabetes, and other chronic diseases, the aged population is one of the main groups at risk. Given that these variables are combined with a sedentary and inactive lifestyle, the steadily growing middle class population and the global urbanisation rate also raise the risk of chronic diseases. Therefore, not only among the elderly population but also among young people, cases of obesity and diabetes have been increasing tremendously. Along with patient-centered care, the healthcare sector also offers preventative health services, which makes it possible for the retail, telecommunications, technology, and wellness and fitness segments to bring cutting-edge solutions for the management of chronic diseases.
The IT healthcare services and advanced digital technologies have gathered a lot of traction in recent years, proving to be instrumental in the growth of the chronic disease management industry. The market gets further boost form the increased adoption of health information technologies and the various online resource options available in healthcare. Studies confirm that in 2015, close to 36 million patients leveraged the Medicare reimbursement policy for chronic disease management services. Intense rivalry between top services providers in the market is observed, which prompts these players to come up with a variety of schemes that draw in a higher number of consumers.
Chronic disease management market has been gaining significantly on the back of growing adoption of health information-based technologies as well as online healthcare platforms. The market is characterized by a high number of partnerships, collaborations and acquisitions between healthcare firms and leading firms, which also enhance the market size. For instance, in October 2022, Aetna partnered with Landmark Health to use home healthcare for addressing chronic disease management. The partnership will allow the patients to be safe at home and aim to offer effective treatment for chronic conditions.
The chronic disease management market size has been categorized depending on solution, delivery mode, application, and end user.
The solutions covered in the extensive market study include consulting solution, educational solution and implementation solution, among others.
The significant application areas are safety arthritis, cardiovascular disease, cancer, diabetes, and others.
On-premises along with web-based and cloud-based are some of the key delivery modes analyzed in the report.
Payers, providers, and others are the prominent end-users in the worldwide market.
Chronic Disease Management Market players:
- TriZetto Corporation (US)
- EXL Healthcare (New York)
- Infosys Limited (India)
- Pegasystems Inc. (US)
- ScienceSoft USA Corporation (US)
- Allscripts Healthcare Solutions Inc. (US)
- Harmony Information Systems Inc.(US)
- Koninklijke Philips NV (Netherlands)
- MINES & Associates Inc. (US)
- Siemens Healthcare Private Limited (Germany)
The MRFR report has studied the chronic disease management market size and its expected growth rate across the key regions of Europe, MEA/Middle East & Africa, the Americas and APAC/Asia Pacific.
The Americas could be the highest gainer in the global market during the conjectured period, thanks to the heightened demand for chronic disease management in view of the surging cases of diabetes, cancer and more along with the significant funds allocated for research and development/R&D for biotech and pharma companies. The United States is home to the top 10 chronic care management companies in the world, such as ScienceSoft USA Corporation and Allscripts Healthcare Solutions Inc., which also works in the market’s favor.
Given the sharp rise in health-related issues among people and the fast growing geriatric population, Europe is predicted to overtake the United States as the second-largest market in the near future. These factors are increasing the amount spent on advanced healthcare services, and the government is also creating policies that support the adoption of cutting-edge treatments like chronic disease management.
APAC will be racing ahead at the fastest speed over the coming years, on account of the booming population combined with the rampant demand for innovative and effective treatments and services. The discerning surge in cancer cases in the developing countries of Japan, Hong Kong and India is leading the regional market to greater heights. The rising trend of medical tourism in the region and the promising growth of healthcare IT also benefit the chronic condition management market in Asia Pacific.
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)